Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Chikungunya Virus May Lead to Long-Term Joint Pain

  |  

For now, Dr. Chang says prevention is key.

“DEET works better than other insect repellants for mosquitoes and can prevent transmission of the CHIKV and Zika viruses,” Dr. Chang says. “Patients traveling to a hot, humid area where infection cases have been reported should be encouraged to use DEET over their sunscreen as a precaution.”

ADVERTISEMENT
SCROLL TO CONTINUE

Linda Childers is a health writer located in the San Francisco Bay Area.

References

ADVERTISEMENT
SCROLL TO CONTINUE
  1. Chang AY, Tritsch SR, Encinales L, et al. Chronic joint pain three years after chikungunya virus infection largely characterized by relapsing-remitting symptoms. J Rheumatol. 2020 Aug 1;47(8):1267–1274. Epub 2019 Jul 1.
  2. Centers for Disease Control & Prevention. Chikungunya virus. 2019 Sep 19.
  3. Chang AY, Encinales L, Pacheco N, et al. Frequency of chronic joint pain following a chikungunya virus infection: A Colombia cohort study. Arthritis Rheumatol. 2018 Apr;70(4):578–584. Epub 2018 Mar 2.
  4. Hackett DW. Chikungunya vaccine candidate to begin testing in Europe. Precision Vaccination. 2020 Jan 14.

Related Articles

    Mosquito-Borne Chikungunya Virus Can Cause Long-Term Arthritis

    Chikungunya is among a group of 16 diseases transmitted through mosquito, tick or flea bites that is of increasing public health concern in the U.S. Although few rheumatologists are likely to diagnose patients with the acute phase of the disease, they may encounter a handful of patients each year who complain of persistent, and often…

    Chikungunya Virus Vaccine Shows Promise in Early Clinical Trial

    NEW YORK (Reuters Health)—A new chikungunya virus-like-particle vaccine appears to be safe and immunogenic, according to results from a phase 2 trial. “The phase 2 safety, tolerability and immunogenicity were similar to the data seen in an earlier phase 1 study,” Grace L. Chen, MD, of the National Institutes of Health Vaccine Research Center, Bethesda,…

    Experimental Drug Combination Curbs Chikungunya Arthritis in Mice

    Doctors have had few options to treat the chronic rheumatoid arthritis-like symptoms associated with chikungunya virus infections beyond over-the-counter pain relievers. A recent study in Science Translational Medicine has spurred new optimism by finding that a combination therapy—the anti-rheumatic drug abatacept paired with a chikungunya-neutralizing monoclonal antibody—abolished acute symptoms in infected mice.1 The strategy must…